Explore ViiV Healthcare

I am a
  • HCP
  • person living with HIV
  • NGO or patient group
  • job seeker
  • member of the public
  • academia / entrepreneur
  • media
...looking for
  • information about VHC medicines
  • clinical data and insights on VHC medicines
  • Independent Medical Education
  • medicines in development
  • how VHC is advancing HIV treatment and care
...looking for
  • information about VHC medicines
  • information and support about living with HIV
  • how to report a side effect
  • news and stories from ViiV Healthcare
...looking for
  • funding / grants
  • ViiV Healthcare's approach to partnerships
  • how ViiV Healthcare works with NGOs
  • news and stories from ViiV Healthcare
  • connect with ViiV Healthcare's community
...looking for
  • job opportunities
  • information about ViiV Healthcare
  • ViiV Healthcare's office locations
  • news and stories from ViiV Healthcare
...looking for
  • who are ViiV Healthcare
  • corporate ethics & compliance
  • news and stories from ViiV Healthcare
...looking for
  • opportunities to partner with ViiV Healthcare
  • information on ViiV Healthcare's Innovation Unit
  • news and stories from ViiV Healthcare
...looking for
  • press releases
  • ViiV Healthcare's Leadership
  • news and stories from ViiV Healthcare

Our medicines

Product brand name
(generic name)
Class
3TC® (lamivudine) Nucleoside reverse transcriptase inhibitor (NRTI)
Celsentri® (maraviroc) CCR5 antagonist
Combivir® (lamivudine/zidovudine) Nucleoside reverse transcriptase inhibitor (NRTI)
Juluca® (dolutegravir/rilpivirine) Integrase inhibitor (INI) and Non-nucleoside reverse transcriptase inhibitor (NNRTI)
Kivexa® (abacavir/lamivudine) Nucleoside reverse transcriptase inhibitor (NRTI)
Retrovir® (zidovudine) Nucleoside reverse transcriptase inhibitor (NRTI)
Telzir® (fosamprenavir) Protease inhibitor (PI)
Tivicay® (dolutegravir) Integrase inhibitor (INI)
Triumeq® (dolutegravir/abacavir/lamivudine) Integrase inhibitor (INI) and Nucleoside reverse transcriptase inhibitor (NRTI)
Trizivir® (abacavir/lamivudine/zidovudine) Nucleoside reverse transcriptase inhibitor (NRTI)
Ziagen® (abacavir) Nucleoside reverse transcriptase inhibitor (NRTI)

 

Date of preparation: June 2018 | AUS/HIV/0077/18